openPR Logo
Press release

Reus Research Rebrands as Cata-Kor: A New Era of Innovation in NAD+ Enhancement

03-05-2025 02:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Reus Research Rebrands as Cata-Kor: A New Era of Innovation

Pioneering the Future of NAD+ Supplementation with Advanced LipoNAD+ Technology and a Renewed Commitment to Scientific Excellence.
Miami, FL - Mar 5, 2025 - Reus Research, a leader in NAD+ supplementation and longevity science, is officially rebranding as Cata-Kor [https://catakor.com/], marking a bold step forward in its commitment to innovation, scientific integrity, and superior health solutions.

"We are evolving beyond our original identity to reflect our advancements in longevity science while staying true to our mission of supporting elevated NAD+ levels for better health and vitality," said Uladzimir Seuruk [https://www.linkedin.com/in/vlad-seuruk-838b9210b], Founder & CEO of Cata-Kor. "With this transition, we are introducing a groundbreaking new formula, enhanced technology, and a stronger commitment to quality."

As part of the rebrand, Cata-Kor is unveiling a revamped formula that eliminates Nicotinamide Riboside (NR) and Quercetin, replacing them with patented LipoNAD+ and Resveratrol. The exclusive LipoNAD+ technology features a lipid-coated delivery system that bypasses stomach breakdown and is more readily absorbed in the intestines, optimizing cellular energy production and repair. Additionally, Cata-Kor is reinforcing its commitment to quality and transparency by shifting to 100% U.S.-based production, ensuring every supplement meets the highest safety and manufacturing standards.

Despite these changes, Cata-Kor [https://catakor.com] remains dedicated to its core mission. The supplement continues to elevate NAD+ levels, supporting energy, longevity, and cellular health. The formula remains scientifically backed, with each serving delivering 500 mg of active ingredients for optimal results. Cata-Kor products will continue to be available on TikTok Shop and Amazon, ensuring accessibility for health-conscious consumers.

Leading this transformation is Seuruk, the pioneering researcher behind the brand. While the name has evolved, Cata-Kor's [https://catakor.com] signature packaging and recognizable product color remain unchanged, maintaining continuity and trust with its customers.

This rebranding marks a pivotal moment in longevity science, reinforcing Cata-Kor's commitment to cutting-edge innovation and consumer trust.

For more information, visit https://catakor.com [https://catakor.com].

Media Contact
Company Name: Otter PR
Contact Person: Mark Hashem
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=reus-research-rebrands-as-catakor-a-new-era-of-innovation-in-nad-enhancement]
Phone: 7274339069
Address:100 E Pine St Suite 110
City: Orlando
State: Florida
Country: United States
Website: http://OtterPR.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Reus Research Rebrands as Cata-Kor: A New Era of Innovation in NAD+ Enhancement here

News-ID: 3899476 • Views:

More Releases from ABNewswire

KRAS Inhibitors Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Target Population, Revenue, Statistics, MOA, ROA and Companies DelveInsight
KRAS Inhibitors Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Ta …
KRAS Inhibitors companies working in the market are Novartis, Roche, Genentech, Verastem Oncology, Revolution Medicines, Cardiff Oncology, Immuneering Corporation, Jacobio Pharmaceuticals, BridgeBio Pharma (Navire Pharma), Mirati Therapeutics, Deciphera Pharmaceuticals, Elicio Therapeutics, InventisBio, Gritstone Bio, D3 Bio, and others (Albany, USA) In 2024, the United States held nearly 70% of the KRAS inhibitors market across the 7MM, driven by a high burden of KRAS-mutated cancers, especially NSCLC, which accounts for 46% of
$33 Billion for Drones: How the One Big Beautiful Bill Creates a New Defense Boom (ZENA, KTOS, AVAV, LHX)
$33 Billion for Drones: How the One Big Beautiful Bill Creates a New Defense Boo …
The One Big Beautiful Bill, also known as H.R. 1, was signed into law by President Trump on July 4, 2025. It delivers one of the largest federal investment packages in recent memory, combining permanent tax changes with over $150 billion in new defense spending and another $150 billion for border security, ICE, and related initiatives. Rather than broad stimulus, this law directs funds toward high-priority national capabilities with focused
MASH Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Statistics, Revenue, Patient Pool, MOA, ROA and Companies by DelveInsight
MASH Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication …
MASH Companies are Hepion Pharmaceuticals, Ionis Pharmaceuticals, Galectin Therapeutics, Novo Nordisk A/S, Cirius Therapeutics, HighTide Biopharma, Boehringer Ingelheim, Hepagene, Eli Lilly and Company, Pfizer, Lipocine, Corcept Therapeutics, Poxel SA, Enyo Pharmaceuticals, Akero Therapeutics, Zydus Therapeutics, 89bio, Viking Therapeutics, Boston Pharmaceuticals, Gilead Sciences, Merck & Co., Zealand Pharma, Hanmi Pharmaceutical, Inventiva Pharma, CytoDyn, Sagimet Biosciences, and others. Metabolic dysfunction-associated Steatohepatitis Market Summary According to DelveInsight, the MASH (Metabolic dysfunction-associated steatohepatitis) market across the
After the Mic Drop: Why American Rebel (NASDAQ: AREB) Could Be the Most Underrated Brand Story in America
After the Mic Drop: Why American Rebel (NASDAQ: AREB) Could Be the Most Underrat …
If you tuned into the recent live interview [https://x.com/Barchart/status/1942962125783330953] with American Rebel CEO Andy Ross-whether on X or in print-chances are, you came away with one conclusion: this isn't your typical beverage company. This is something bigger. Bolder. And far more timely. As the company puts it, "America's Patriotic, God-Fearing, Constitution-Loving, National Anthem-Singing, Stand Your Ground Beer." Following the full-length executive Q&A and a high-energy livestream event that brought out fans and

All 5 Releases


More Releases for NAD+

ABBA Raises NAD $2.2M in Seed Funding
Namibia-based Africa Better Business Agency (ABBA) which is developing the ABBA Accredited Network to advance trust and transparency in cross-border transactions in Africa, raised USD $130,000 (NAD $2.2 million) in seed funding from the New York City, USA based SNR Capital Management LLC and Columbus, Ohio USA based First Cascade Equity Partners LLC. The company intends to use the funds to finalize the development of its core offerings, the ABBA
Nicotinamide Adenine Dinucleotide (NAD) Market Size, Status and Business Outlook …
Nicotinamide Adenine Dinucleotide (NAD) Market 2021 Analysis by Leading Players - EnzymeWorks, Bontac Bio-engineering, Hubei Widely Chemical Technology The Nicotinamide Adenine Dinucleotide (NAD) Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This
Nicotinamide Adenine Dinucleotide (NAD) Market Installed For Attached Leg Of Mas …
Report Ocean recently published a new report on the Global Nicotinamide Adenine Dinucleotide (NAD) Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Nicotinamide Adenine Dinucleotide (NAD) Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Nicotinamide Adenine Dinucleotide (NAD) Market situation of the leading key
Oklahoma Conference Proposes Bylaws Change Aligning Themselves with the NAD
Fulcrum7.com, April 16, 2021 – The Oklahoma Conference of Seventh-day Adventists holds their regular Conference Constituency Meeting this Sunday on April 18th. Delegates received a paper outlining bylaws changes just a couple days ahead of the meeting. One of the proposed changes affecting the relationship of the Oklahoma Conference to the world Church is substantive. Constitution & Bylaws Changes • Notice how the proposed changes (line 19) inserts the North American Division (NAD)
Private LTE nad 5G Network Market Evolving Technology and Growth Outlook 2020 to …
The report elaborates the complete details covering product definition, product type, and application. The report covers useful details which are categorized based on Private LTE & 5G Network production region, major players, and product type which will provide a simplified view of the Private LTE & 5G Network industry. The Private LTE & 5G Network market report presents the competitive scenario of the major market players based on the sales
Photography Lighting Equipment Market Analysis by top key players Manfrotto, OSR …
Scope of the Report: The worldwide market for Photography Lighting Equipment is expected to grow over the next five years, according to a new GIR (Global Info Research) study. This report focuses on the Photography Lighting Equipment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/3119501?utm_source=OPR&utm_medium=Shifali This report categorizes the market based on manufacturers, regions, type and application. Market